Phase III trial of tacrolimus [LCP-Tacro] compared with ciclosporin in de novo kidney transplant recipients receiving mycophenolate mofetil and corticosteroids.

Trial Profile

Phase III trial of tacrolimus [LCP-Tacro] compared with ciclosporin in de novo kidney transplant recipients receiving mycophenolate mofetil and corticosteroids.

Not stated
Phase of Trial: Phase III

Latest Information Update: 11 Mar 2013

At a glance

  • Drugs Tacrolimus (Primary) ; Ciclosporin; Corticosteroids; Mycophenolate mofetil
  • Indications Renal transplant rejection
  • Focus Registrational; Therapeutic Use
  • Sponsors Veloxis Pharmaceuticals
  • Most Recent Events

    • 11 Mar 2013 Status changed from planning to unconfirmed.
    • 11 Jun 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top